What does CUSIP 15117B103 represent in this 13F holders report?

CUSIP 15117B103 is the security identifier for CLDX - CELLDEX THERAPEUTICS INC NEW - COM used to aggregate holder disclosures.

How many institutions held CLDX - CELLDEX THERAPEUTICS INC NEW - COM in Q3 2016?

133 institutional investors reported CLDX - CELLDEX THERAPEUTICS INC NEW - COM for Q3 2016. Use the holders table for investor-level position and value details.

CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2016 13F Holders as of 30 Sep 2016

Security type / class: Equity / COM
Total 13F shares: 69,756,748
Total 13F value: $281,693,259
Share change: -9,472,192
Put/Call ratio: 126%
SEC-reported price per share: $4.04
Number of holders: 133
Value change: -$41,935,150
Number of buys: 57
Number of sells: 60

Security key

15117B103

Report period

Q3 2016

Institutions

133

Top holders

CLDX full security history Ownership snapshot Full 13F holder table Celldex Therapeutics, Inc. SEC filings Celldex Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CLDX - CELLDEX THERAPEUTICS INC NEW - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

0/15

Latest evidence

30 Jun 2016

13F Highest disclosed value: $60,922,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $60.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Disclosed position value Top 5

FMR LLC $60.92M

OppenheimerFunds, Inc. $40.22M

VANGUARD GROUP INC $31.89M

FRANKLIN TEMPLETON INC $27.69M

COLUMBIA WANGER ASSET MANAGEMENT LLC $23.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	— denominator unverified	$60,922,000 13,877,416 shares	—	30 Jun 2016
OppenheimerFunds, Inc.	13F Company 13F	— denominator unverified	$40,223,000 9,162,610 shares	—	30 Jun 2016
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$31,886,000 7,263,339 shares	—	30 Jun 2016
FRANKLIN TEMPLETON INC	13F Company 13F	— denominator unverified	$27,692,000 6,307,998 shares	—	30 Jun 2016
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$23,100,000 5,261,934 shares	—	30 Jun 2016
STATE STREET CORP	13F Company 13F	— denominator unverified	$21,829,000 4,972,469 shares	—	30 Jun 2016

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

133

69,756,748

Rows available

133

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders

138

Q3 2016 holders

133

Holder diff

-5

Investor	Q2 2016 Shares	Q3 2016 Shares	Share Diff	Share Chg %	Q2 2016 value	Q3 2016 value	Value change	Value Chg %